Healthcare -
Biotechnology - NASDAQ - US
$ 8.09
-1.17 %
$ 838 M
Market Cap
-1.45
P/E
NTLA - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities NTLA - Intellia Therapeutics, Inc.
126 M
LAST VALUE
-11.50%
2 YEAR CAGR
37.90%
5 YEAR CAGR
64.78%
10 YEAR CAGR